Companies
Is Autolus Therapeutics plc (NASDAQ:AUTL) Still Worth A Bite?
Autolus Therapeutics plc (NASDAQ:AUTL) Relative Strength Index (RSI) is 70.26, with weekly volatility at 9.35% and ATR at 0.58. The AUTL stock’s 52-week price range
Autolus Therapeutics plc (NASDAQ:AUTL) Relative Strength Index (RSI) is 70.26, with weekly volatility at 9.35% and ATR at 0.58. The AUTL stock’s 52-week price range
Autolus Therapeutics plc (NASDAQ:AUTL) shares fell to a low of $6.64 before closing at $6.86. Intraday shares traded counted 1.92 million, which was -74.45% lower
Autolus Therapeutics plc (NASDAQ:AUTL) previous close was $6.36 while the outstanding shares total 52.21M. AUTL’s shares traded higher over the last trading session, gaining 4.25%
Autolus Therapeutics plc (NASDAQ:AUTL) previous close was $6.73 while the outstanding shares total 52.21M. AUTL’s shares traded lower over the last trading session, losing -5.50%
Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.
All rights reserved © 2024, Powered by Smart TechOne